Why Attend
Animal Health Innovation Asia is a premier B2B conference showcasing emerging Animal Health and Nutrition companies, from Japan and across Asia-Pacific, that are actively seeking financial investment or strategic partnership conversations with large corporate firms.
Our plenary sessions provide guidance on veterinary market trends and animal health industry dynamics in Japan & APAC, insight on how emerging companies are using new innovations to prevent disease and market analysis on the M&A activity across the animal health and nutrition markets in Asia.
Testimonials
"This is a unique event for our animal health industry. It brings local and international players together, and provides an excellent platform to build business partnerships.”
Tony Zilong Tan, Z-Link Biotech Co. Ltd.
“This meeting is a very exciting one – it’s a platform to meet everyone from Chinese animal health and International animal health companies, and to introduce them to one-another. This way you save time and it gives you more chance to keep ahead of the innovations.”
Tingwu Xue, China Animal Husbandry Group (CAHG)
“I think this is a great meeting for companies to come together and find out what the common challenges are and how they can work together. I’m really impressed!"
Jishu Shi, U.S.-China Centre for Animal Health
"Everybody’s here, you can have many meetings in one spot, learn how to work together, increase your network and search for ideas.”
Joachim Hasenmaier, Boehringer-Ingelheim
Highlights from the Series
Innovation Showcase
Eight start-up companies from Japan will present their novel technologies to an audience of strategic partners from APAC, Japan and around the world. These start-ups are animal health and nutrition companies who are actively seeking financial investment or strategic partnerships.
University Pavilion
Connecting Academia with Business Partners
Leading Universities and Technology Licencing Organisations (TLOs) from Japan will present their research and partnership opportunities in a special session on the main stage. Each instititon will bring with them a start-up company that is currently looking for strategic partners.
Consulting Partner
We’re delighted to have AHRMS, Inc. join us as the consulting partner for Animal Health Innovation Asia 2019. Dr. Yuki Ujimasa, DVM, MS, President of AHRMS, Inc. and his team have been supporting companies entering into Japanese markets since 2006.
Who You Will Meet
Attendees will represent the following key stakeholder groups in the Animal Health market
- Heads of Business Development, Animal Health, R&D from Multinational Pharmaceutical Companies
- CEOs, CSOs and Heads of Business Development from Emerging Animal Health Companies
- CEOs, Heads of Business Development, Product Discovery and Marketing from Incubators/ Accelerators, Contract Research Orgs, Consultants, Lawyers and other Service Providers
…all of the above with an interest in Livestock, Aquaculture and the Companion Animal markets
Attendees expected from the following key stakeholder groups and organizations
Headline Partner
ZENOAQ
Website: http://www.zenoaq.jp/english/index.html
ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.
Associate Partners
Boehringer Ingelheim
Website: http://www.boehringer-ingelheim.com
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates presently with a total of some 50,000 employees worldwide. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.
For more information, please visit www.Boehringer-Ingleheim.com
Ceva
Website: http://www.ceva.co.uk
Ceva Santé Animale (Ceva) is one of the fastest growing top 10 veterinary healthcare companies. We research, develop and produce vaccines and pharmaceutical products for poultry, companion animals, livestock and swine.
Ceva has been directly present in China for over 15 years and is heavily invested through R&D partnerships and local production of vaccines.
Ceva Huadu, Beijing focuses on poultry vaccine production and the recently formed Ceva Ebvac, Hangzhou City, will drive the rapidly expanding swine vaccine business
Since 2011, Ceva has entered into a number of scientific cooperation agreements (South China Agricultural University (SCAU), University of Beijing) designed to share knowledge and ensure that the company’s international poultry and swine expertise can be applied to local conditions in China.
Globally, Ceva is one of the leading poultry healthcare suppliers having driven innovation in hatchery vaccination, to improve efficiency and performance. Ceva’s C.H.I.C.K programme was the first hatchery services programme to be independently approved by the international standards company, Bureau Veritas. Demonstrating the company’s commitment to help its customers to constantly enhance their productivity through different means of innovation.
In swine, the company has a balanced portfolio of vaccine and pharmaceutical products that are also supported by extensive veterinary and technical services programmes (Lung programme, Respinomics).
Our growth in China, reflects the entrepreneurial nature of Ceva, which is owned and managed by its senior management team. 40% of our growth has come from the more than 30 acquisitions and innumerable license agreements that we have made since 2000. As a result, we are always open to receiving innovation proposals to generate growth in China and beyond.
Elanco
Website: http://www.elanco.com
Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. We understand the powerful role healthy animals play in making lives better. We support the physical, emotional and social well-being of people thru a balanced diet rich in protein and the companionship of a pet. And, we preserve the health of the planet by helping farmers raise animals more efficiently. Since our start at Eli Lilly and Company in 1954, Elanco has been working to empower our customers—from veterinarians to food producers to all those concerned with animal health—to address these global challenges, and advance a vision of food and companionship enriching life. Visit us at Elanco.com and EnoughMovement.com.
IDEXX
Website: http://www.idexx.com
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry, and testing for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries.
Our purpose is to be a great company that creates exceptional long-term value for our customers, employees, and shareholders by enhancing the health and well-being of pets, people, and livestock.
For more information about IDEXX, visit: www.idexx.com
Zoetis
Website: http://www.zoetis.com
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees.
For more information, visit www.zoetis.com.
Consulting Partner
AHRMS, Inc.
Website: https://ahrms.jp/wp/
Tokyo-based AHRMS, Inc., have provided regulatory consultancy and marketing services to Japanese and foreign animal health companies since 2006.
We also register animal health products by acting as D-MAH (designated marketing authorization holder) for foreign manufacturers. This means that our client companies can receive marketing approvals from Japanese authorities without establishing their subsidiary in Japan.
Our services cover animal medicines, biologicals, medical devices, and in vitro diagnostic kits. We strongly hope that we could support your entering into Japanese markets.
Event Partners
Argenta
Website: http://www.argentaglobal.com
Argenta Limited, founded in 2006, is the world’s only combined contract research organization (CRO) and contract manufacturing organization (CMO) specializing in animal health. With accredited operations and facilities across New Zealand, the United States and Scotland, Argenta is fully equipped to offer a full range of products and services - from access to innovative intellectual property, formulations research and development (R&D), analytical methods development, clinical trial management through to pilot- technical transfer and commercial-scale manufacturing - to the global animal health industry. Argenta’s 400+ global team develops and exports products and services to over 40 countries.
A privately-owned company headquartered in Auckland, New Zealand, Argenta brings innovation, R&D and manufacturing expertise together in one global company. This makes it ideally placed to accommodate unique product requirements no matter the scale or complexity. Argenta’s facilities in New Zealand, the United States (Iowa, Kansas and New Jersey) and Europe (Scotland) enable the achievement of significant efficiencies in product development and technology transfer, and to provide market intelligence and in-depth knowledge of market preferences in different countries as required.
Argenta is honoured to work with a vast range of clients globally - from small and medium-sized enterprises (SMEs) to some of the largest industry players. Argenta has the R&D capabilities and manufacturing scale to service the requirements of the largest multinationals, while, at the other end of the spectrum, Argenta works with startups and small companies with great ideas to help them find solutions and bring their ideas to fruition.
For more information, please visit www.argentaglobal.com.
Klifovet
Website: http://www.klifovet.com
KLIFOVET provides high quality services for the animal health and animal nutrition industry regarding the registration and marketing of all kind of veterinary products. We support ambitious young biotech and veterinary pharma companies on their way to the top by providing full business and product development management, regulatory affairs consultancy including dossier writing, compilation and submission, and full CRO services for safety and efficacy studies. We are proud on 18 years of experience, well organized logistics, a highly motivated team, and a comprehensive net of co-operators and skilled investigators throughout Europe, North America and the world. We handle large multinational projects as professionally as national ones, complying to national, EMA, EFSA or FDA standards.
The Department for International Trade (DIT)
Website: https://www.great.gov.uk/
The Department for International Trade (DIT) helps businesses export and grow into global markets. We also help overseas companies locate and grow in the UK - our services are provided in over 100 markets throughout the world.
We secure UK and global prosperity by promoting and financing international trade and investment, and championing free trade.
We are an international economic department, responsible for:
- bringing together policy, promotion and financial expertise to break down barriers to trade and investment, and help businesses succeed
- delivering a new trade policy framework for the UK as we leave the EU
- promoting British trade and investment across the world
- building the global appetite for British goods and services
Media Partners
All About Feed
Website: http://www.allaboutfeed.net
All About Feed is a true multimedia brand, bringing you the latest developments in animal nutrition, diet formulation, and feed processing equipment. We deliver the best articles right in your inbox - subscribe for our e-mail newsletter by clicking here.
Animal Pharm
Website: https://animalpharm.agribusinessintelligence.informa.com
We have been providing animal health professionals worldwide with news, analysis and insight for over 30 years, and cover the food producing animal and companion animal sectors. With extensive information on animal health products including antiparasitics, vaccines, pharmaceuticals, feed, feed additives and equipment.
Features include:
- Analysis of business and company news
- Reporting on key players in the industry
- Market developments and trends
- Analysis of the latest global regulatory changes
- News on product research and development
- Expert opinion and analysis
eFeed Link
Website: http://www.efeedlink.com
International Pig Topics
Website: http://positiveaction.info/
The technical magazine for professional pig producers that focuses on the key issues of nutrition, environment, management, breeding and health.
Published 8 times each year it offers technical articles that are easy to read, short refresher articles and reviews of the latest research and products. This makes International Pig Topics essential reading for today's leading pig producers.
Japan Veterinary Products Association (JVPA)
Website: http://jvpa.jp/jvpa/?p=1229
Japan Veterinary Products Association (JVPA) is a public interest incorporated association for the support of development, improvement and spread of pharmaceuticals, bioligics, quasi-drugs and medical devices used for animals, aiming at contribution to the improvement of animal health. As of April 1st, 2013, JVPA consists of 68 full membership companies and 20 supporting (individual) companies.
Watt Global Media
Website: http://www.wattglobalmedia.com/
As an industry innovator, WATT Global Media has connected buyers and sellers in the poultry, animal feed and pet food industries through its media channels for 100 years.
Become a Sponsor
Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at partner@kisacoresearch.com.
The Agenda
You can download our latest agenda here.
Following another brilliant event in Hong Kong last year, Animal Health Innovation Asia moves to Japan for 2019.
Take a look at the agenda here - simply fill in this form and we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.
Download the Agenda
Speakers
Clinton Lewis
Clint Lewis is executive vice president and president of International Operations at Zoetis. In this role, he oversees the management of the livestock and companion animal business markets outside the United States.
Mr. Lewis previously served as president, U.S. Operations at Zoetis and in the Pfizer Animal Health organization. He joined Pfizer Animal Health in 2007.
Mr. Lewis joined Pfizer in 1988 as a sales representative in Long Island, N.Y., and has held positions of increasing responsibility in several areas across various commercial operations dedicated to human health prior to joining animal health, including vice president and general manager of Pfizer’s U.S. Anti-Infectives/HIV business unit.
In 2011, Mr. Lewis was elected chairman of the Animal Health Institute (AHI) for the 2011-12 term. A member of AHI since 2007, Mr. Lewis previously served as AHI vice chair for the 2009-2010 term. AHI is the trade association for the animal health industry in the U.S. advocating on various issues important to the industry, including efficient and effective regulatory and approval processes by the U.S. Department of Agriculture (USDA), the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA).
Mr. Lewis holds a bachelor’s degree in biology from Fairfield University and a Master of Business Administration in marketing from Fairleigh Dickinson University.
Dr. Ken Noda
Dr. Noda is the Executive Research Officer of National Veterinary Assay Laboratory (NVAL), Ministry of Agriculture, Forestry and Fisheries of Japan (JMAFF); Directing Biotech/Regenerative Veterinary Medicine Team responsible for approval of veterinary medicinal products (VMPs) developed with emerging technology as well as research in quality assurance methodology for such products, Serving as a Research Advisory Board Member in the institute. He also has administrative experiences as Deputy Director for VMP-Administration at Food Safety and Consumer Affairs Bureau at JMAFF Head Quarter. Outside JMAFF activity, he has been serving as a Steering Committee member of VICH (international cooperation and harmonization for VMPs) and OIE National Focal Point for Veterinary Products, for nearly ten years. He is a veterinarian and holds a PhD degree from the University of Tokyo, research experiences in veterinary biochemistry, bacteriology and regulatory science. Before joining JMAFF, he has been teaching biochemistry and physiology at University of Tokyo and Tottori University as an associate professor.
Dr. Koji Oishi
Since 1986 to 1996, Dr. Koji Oishi spent many years in the MAFF’s head office and the NVAL, being engaged in both administrative and laboratory work in evaluation of the veterinary pharmaceuticals and biologicals. During this period, he was sent to Indonesia as an expert on quality control of veterinary medicine in 1990 under the JICA project.
He was assigned to The Embassy of the Japan in URUGUAY (1996-1999) as the First Secretary, where he gained knowledge on animal health and other agricultural and livestock issues in South America countries.
Before Dr. Oishi returned the NVAL, he was the Deputy Director of the Risk Assessment Division of the Food Safety Commission(2003-2005) and the Deputy Director of the Animal Products Safety Division of MAFF (1999-2002, 2005-2008), where he acquired his knowledge in veterinary pharmaceuticals and animal production food safety regulations.
Since 2015 to 2018, he has been in charge of “Director, Assay Division 1, National veterinary Assay Laboratory” and retired.
Marc Prikazsky
Mr. Toshikazu Fukui
2008 - 2011: Division Director of International Business based at the Zenoaq Beijing Representative Office
2011- 2016: Company President of Nippon Biologicals, Inc. [Zenoaq affiliate]
2013 - 2016: Executive Director of International Business [Zenoaq]
2016: Company President of Vetoquinol Zenoaq K.K.
2016 - 2018: Executive Vice President of Zenoaq
2018 - present: Company President
Kristin Bloink
Kristin Bloink manages all internal discovery efforts and all external technology evaluations and subsequent portfolio entries for R&D. She has 26 years of accomplishments in human clinical trials, animal drug discovery and development, translational model development and execution, and human and veterinary clinical medical delivery in the private as well as the military sector. She joined Novartis Animal Health in 2007 and integrated into Elanco Animal Health in 2015.
Dr. Yuki Ujimasa, DVM, MS
Dr. Aki Miyake DVM
Dr. Aki Miyake graduated from Veterinary Science Department, Faculty of Materials Science and Technology, University of Japan. After working in a small animal clinic, she assumed office at Anicli 24.
To pet owners: We aim to create a hospital where you can feel free to ask us anything. I will be happy if you and your dog or cat are having a happy life.
Mr. Katsutoshi Kato
Mark J. Micallef
Dr. Hajime Tsujimoto
Present position: Professor, Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo
Research interest: Hematopoietic tumors in dogs and cats
Positions in academic societies
- President, Japanese College of Veterinary Internal Medicine (JCVIM)
- Vice President, Asian Society of Veterinary Internal Medicine (AiSVIM)
- Scientific Advisory Committee, World Small Animal Veterinary Association (WSAVA)
Mr. Tadashi Nagata
Dr. Toshiyasu Miyazaki
Mr. Yukio Takene
Mr. Kenta Yamato
Dr. Jing Wang
Dr Jing Wang joined the OIE Regional Representation for Asia and the Pacific in May 2017 as a Regional Veterinary Officer. Her major responsibilities include organization of capacity building training and Antimicrobial Resistance related activities. She has been involving emerging disease response to provide timely technical support to the Member Countries to address the disease incursion and acting as a contact point for the OIE Reference Centres to facilitate and review the implementation of capacity building activities for national veterinary services in the region.
Prior to joining the OIE, she served for China Animal Disease Control Center for several years as assistant professor, focusing on animal diseases laboratory diagnosis as well as laboratory quality management. From 2013-2015, she was seconded to Veterinary Bureau, Ministry of Agriculture, P.R. China, where she gained knowledge on disease control and emerging disease preparedness.
She graduated as Doctor of Veterinary Medicine from China Agriculture University, Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety.
Dr. Benoit Rossingnol
Erwin Blomsma
Erwin Blomsma holds a Master’s degree in Bioscience Engineering and a Ph.D. in Applied Biological Sciences (1995) from KU Leuven in Belgium. After post-doctoral studies at UCB he started his career at Janssen Pharmaceutica in 1996 with a focus on assessing and implementing new technologies. In 2000, he co-founded Crystallics, a spin-off from the University of Leiden (NL) specializing in preformulation research. Crystallics was absorbed by Avantium Technologies in 2001, and he was appointed Chief Operating Officer there in 2004, playing a key role in making the company cash-positive. In 2007, Dr Blomsma joined Dr Stefaan Wera and Professor Johan Neyts as co-founder and CEO of Okapi Sciences and after a series A of 8.5 million EUR end of 2008 the team developed a pipeline of 7 products (2 in pivotal clinical trials) and signed a license deal with Novartis Animal Health in 2013. Okapi Sciences was then acquired by Aratana Therapeutics for 44 million USD in January 2014. From the acquisition to August 2015 he was the General Manager of Aratana Therapeutics NV in Belgium and Vice President of Aratana Therapeutics, Inc. In 2015, Erwin Blomsma co-founded ViroVet. In 2016 ViroVet raised 5 million USD in a series A financing round. Erwin Blomsma is CEO at ViroVet and also the current Chairman of FlandersBio, a cluster organization representing over 350 life sciences companies in Flanders, Belgium.
Larbi van Lier
Kathy V. Turner
Godai Teranishi
Prof. Tomoyoshi Yoshinaga
Dr Tomoyoshi Yoshinaga is a professor of the Department of Aquatic Bioscience at the Graduate School of Agricultural and Life Sciences, the University of Tokyo. After receiving his PhD degree from that university in 1987, he entered the Ministry of Agriculture, Forestry and Fisheries as a researcher, where he worked at the National Research Institute of Fisheries Science and the National Research Institute of Aquaculture. He returned to the University of Tokyo in 2002 as a professor after his fifteen-year career at the ministry. Dr Yoshinaga is still a member of several committees on fish health and animal drugs in the ministry. He has been serving as the president of the Japanese Society of Fish Pathology since 1 April 2019. He has studied mainly fish and shellfish parasites and, for the last ten years, has expanded his interest and activity in the field of biosecurity of aquatic animals.
Mike Wang
Tingwu Xue
Dr. XUE Tingwu is the President of China Animal Husbandry Group. He has been working for the company for over 30 years, with tremendous experience and knowledge in China’s agriculture industry, China’s animal husbandry industry, China’s animal health industry. He also is the pioneer who is dedicated to promote companies which serve safety agro-products and animal-related products to Chinese publics.
He is also actively engaged in various industry-related associations to fulfill his duty to the society. He is the key leading member of China Animal Agriculture Association, and vice-president of China Veterinary Drug Association, etc..
Plus, He is the founder and chairman of China Animal Health International Forum, which has been a platform to share information among animal health companies in order to promote the sustainable development of China animal health industry.
Dr Xu Bing
Education:
PHD, veterinarian, China Agricultural University
Main Working experience:
2010-present, Chairman, Beijing GoldenVet Biotech Co., Ltd.
2002-2010, Chief Representative (China), Virbac
1999-2002, Marketing manager (China), Schering-Plough Animal health.
1997-1999, Regional Sales Manager, Roche (China) Investment Co., Ltd.
1995-1997, Sales Rep, Conti (Beijing) Feed Additives Ltd.
George Ohta
Educational background
Apr.1973～Mar.1977
Graduated from Department of Veterinary Medicine, Faclty of Animal Sciece, Kitasato University
Mar.1977
Veterinary License acquisition (No, 16065)
Oct.2009
Doctor of veterinary medicine
Career history
Apr 2012: Appointed representative Inuyama Animal General Medical Center
Dec 2013: Appointed representative “Team HOPE”
I do a part-time lecturer to students about clinical ethics of clinical veterinarians, current situation and problems of animal hospitals, and surgical diseases in Kitasato University, Iwate University, Miyazaki University and Gifu University.
Also I lecture about “general surgery” and “about management of animal hospital” once or twice a year in overseas such as Taiwan, Korea, China and Thailand.
Register
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Ticket prices will increase in
Venue
The Westin Tokyo, Japan
This year's event takes place at an upscale hotel retreat in central Tokyo: The Westin Tokyo
Located in the quiet area of Ebisu, The Westin Tokyo proudly stands in the ranks of some of the best hotels in Tokyo. Just minutes away from JR Ebisu Station, corporate offices, shopping and entertainment options in Tokyo, the hotel holds one of the best locations in the city.
Address: 1 Chome-4-1 Mita, Meguro-Ku, Tokyo 153-8580, Japan
Phone: +81 3-5423-7000
Website: https://www.marriott.co.uk/hotels/travel/tyowi-the-westin-tokyo/
Price details: 35,000 JPY per night, includes breakfast. This offer expires on October 22nd and is based on availability.
Click here to book at this discounted price.
Global Advisory Board
WHO THEY ARE
Each of our Advisory Board members have been chosen based on numerous recommendations, their deep knowledge and Industry experience and ability to provide a clear vision, not just for their own organizations, but for the industry as a whole.
WHY THEY ARE HERE
Board members guide not just content, but also the underlying mission of the events to drive positive change.
Aaron Schacht
Jishu Shi
Alan Mackay
George Gunn
Linda Rhodes
Joachim Hasenmaier
Clinton Lewis
Dirk Ehle
Dr. James Lloyd
Sébastien Huron
2019 Selection Committee
This esteemed group is responsible for identifying and evaluating innovative emerging companies for presentation as part of our Japan and Asia-Pacific Company Showcases: Each of our committee members has an extensive breadth of experience and knowledge across animal health and nutrition industries and will be available for private meetings at the conference.
Tony Zi Long Tan
Dr. Yuki Ujimasa, DVM, MS
Dr. Jihong Kim
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.